Results 11 to 20 of about 1,457,192 (230)
Pancreatic divisum is the most common anomaly of the pancreas. Pancreatic divisum associated with malignant tumor is rarely seen. The ampulla of Vater is formed by the union of the common bile duct and the pancreatic duct.
Fatma Kulalı +2 more
doaj +2 more sources
Background Although pancreatic neuroendocrine tumors generally have a far better prognosis relative to pancreatic cancer, the varied manifestations lead to treatment-related challenges.
Asahi Sato +8 more
doaj +2 more sources
Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors
Kein-Leong YimVelindre Cancer Center, Cardiff, Wales, United KingdomAbstract: Pancreatic neuroendocrine tumors are rare and the majority of patients present in the advanced stage. Over the past few decades, treatment for patients with metastatic well- or
Yim K-L
doaj +1 more source
Expression studies on PPARγ in pancreatic neuroendocrine tumours [PDF]
MDPancreatic NETs occur with an annual incidence of around 5 per 1,000,000 population per year, with survival rates of between 30 – 97% at 5 years depending on the tumour subtype.
Hanson, Matthew Richard
core +4 more sources
Sporadic nonfunctional pancreatic neuroendocrine tumors: Risk of lymph node metastases and aggressiveness according to tumor size: A multicenter international study. [PDF]
BACKGROUND Although the correlation between tumor size and aggressiveness is clearly established in sporadic nonfunctional pancreatic neuroendocrine tumors, the management of tumors ≤2 cm remains debated.
Yoon, Yoo-Seok +21 more
core +1 more source
Post-surgical Pancreatitis Masquerading as Recurrent Neuroendocrine Cancer [PDF]
Neuroendocrine tumours of the pancreas can have a spectrum of behaviour from relatively benign to aggressive. Resection can result in cure although metastatic disease is described.
Oniscu, Anca +5 more
core +1 more source
Key points Mixed neuroendocrine–non-neuroendocrine neoplasm is a rare pancreatic tumor (0.2%). Pancreatic MiNEN mainly presents as a relatively large heterogeneous mass invading adjacent organs in half of the cases.
Yanqi Zhong +6 more
doaj +1 more source
Lakis et al. report novel findings related to the epigenetic landscape of pancreatic neuroendocrine cancer. This relatively large cohort provides functional insights into the epigenetic wiring of pancreatic neuroendocrine tumor sub-types with the ...
Vanessa Lakis +37 more
doaj +1 more source
The novel mTOR inhibitor RAD001 (Everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells [PDF]
Background/Aim: Tumors exhibiting constitutively activated PI(3) K/Akt/mTOR signaling are hypersensitive to mTOR inhibitors such as RAD001 (everolimus) which is presently being investigated in clinical phase II trials in various tumor entities, including
Brand, Stephan +8 more
core +1 more source
Neoadjuvant therapy for pancreatic neuroendocrine tumors may potentially aid downstaging, increase the possibility of radical surgery. We herein report a case of a 63-year-old man who had been diagnosed with locally advanced small-cell neuroendocrine ...
Keyu Li +5 more
doaj +1 more source

